Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 4378-61-4 | MDL No. : | MFCD00059495 |
Formula : | C22H8Br2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HTENFZMEHKCNMD-UHFFFAOYSA-N |
M.W : | 464.11 | Pubchem ID : | 78084 |
Synonyms : |
|
Num. heavy atoms : | 26 |
Num. arom. heavy atoms : | 22 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 114.59 |
TPSA : | 34.14 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -4.55 cm/s |
Log Po/w (iLOGP) : | 3.1 |
Log Po/w (XLOGP3) : | 6.45 |
Log Po/w (WLOGP) : | 5.96 |
Log Po/w (MLOGP) : | 4.81 |
Log Po/w (SILICOS-IT) : | 7.61 |
Consensus Log Po/w : | 5.59 |
Lipinski : | 1.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 1.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -7.41 |
Solubility : | 0.0000182 mg/ml ; 0.0000000392 mol/l |
Class : | Poorly soluble |
Log S (Ali) : | -6.96 |
Solubility : | 0.0000507 mg/ml ; 0.000000109 mol/l |
Class : | Poorly soluble |
Log S (SILICOS-IT) : | -10.46 |
Solubility : | 0.0000000159 mg/ml ; 0.0 mol/l |
Class : | Insoluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 2.42 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
39% | Stage #1: 2-(2-ethylhexyl)thiophen With n-butyllithium In tetrahydrofuran; hexane at 0℃; for 0.333333h; Inert atmosphere; Stage #2: 4,10-dibromoanthanthrone In tetrahydrofuran; hexane at 0℃; for 1h; Inert atmosphere; Stage #3: With hydrogenchloride; tin(ll) chloride In tetrahydrofuran; hexane; water at 20℃; for 1h; Inert atmosphere; | 4 Synthesis of 4,10-dibromo-6,12-bis(5-isooctyl-2-thienyl)anthracene (AANT): Add 2-octylthiophene (113 mg, 0.58 mmol) and dry tetrahydrofuran (3 mL) to a dry three-necked flask under nitrogen protection and cool to 0°C. A solution of n-butyllithium in n-hexane (2.5M, 0.23mL, 0.58mmol) was slowly added dropwise to the system.After reacting at this temperature for 20 minutes, use a syringe at 0°C to transfer the reaction solution to a nitrogen atmosphere containing compound 1 (100 mg, 0.14 mmol) dissolved in dry tetrahydrofuran. After reacting at this temperature for one hour, 4 mL 10% will be used. A solution of stannous chloride (400 mg, 1.78 mmol) dissolved in hydrochloric acid was added dropwise, and then returned to room temperature, and reacted for another 1 hour.The reaction was quenched with water, and the organic layer was extracted twice with dichloromethane.The organic layer was dried with anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. The crude product was purified by silica gel column chromatography (petroleum ether/dichloromethane 2:1 v/v) to obtain compound 5 as a yellow solid (57mg, 39%) . |
39% | Stage #1: 2-(2-ethylhexyl)thiophen With n-butyllithium In tetrahydrofuran; hexane at 0℃; for 0.333333h; Inert atmosphere; Stage #2: 4,10-dibromoanthanthrone In tetrahydrofuran; hexane at 0℃; for 1h; Inert atmosphere; Stage #3: With hydrogenchloride; tin(II) chloride dihdyrate In tetrahydrofuran; hexane; water at 20℃; for 1h; Inert atmosphere; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | With Aliquat 336; sodium hydroxide at 60℃; for 3h; Inert atmosphere; | 1 Synthesis of 4,10-dibromo-6,12-bis(2-ethylhexaneoxy)anthracene (AAN): Under the protection of nitrogen,Packed in a 250ml single-neck bottleVat Orange 3(500mg, 1.08mmol), sodium hydroxide solution (0.1m, 50mL, 5mmol), Aliquat 336 (530mg, 0.6mL, 1.31mmol), sodium hydroxide (485mg, 2.78mmol), and bromoisooctane (1.5mL , 1.66g, 8.62mmol). The reaction solution was heated to 60°C for 3h until the reaction system became colorless. Pour out the water gently, and then add 30 mL of methanol. The crude product was filtered off with suction, and then washed with methanol. Purified by silica gel column chromatography (dichloromethane/petroleum ether 1:2v/v) to obtain compound 2 as an orange solid (544mg, 73%). |
73% | With sodium dithionite; sodium hydroxide In water at 80℃; for 3h; Inert atmosphere; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; water; palladium diacetate; cesium fluoride; cyclo-octa-1,5-diene at 120℃; for 1.5h; Milling; | |
43% | Stage #1: 4,10-dibromoanthanthrone; 4-(diphenylamino)phenyl boronic acid With dichloro[1,1'-bis(di-t-butylphosphino)ferrocene]palladium(II) In water at 20℃; for 0.0833333h; Stage #2: With triethylamine In water at 80℃; for 12h; | 2.3.2. Compounds 1-7, 10 General procedure: Aryl bromide (0.5 mmol, 1 eq.), aryl boronic acid (1.5 mmol, 3 eq.) and Pd(dtbpf)Cl 2 (0.01 mmol, 0.02 eq.) were weighed in the test tube and 3 mL of 2 wt% of l - α-lecithin and Tween 80 (2:8) solution in water were added. The mixture was stirred for 5 min at room temperature, then Et 3 N (3 mmol, 6 eq.) was added. After 12 h, the mixture was diluted with 20 mL of MeOH and filtered. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | Stage #1: 4,10-dibromoanthanthrone; 3,5-di-tert-butylphenyl boronic acid With dichloro[1,1'-bis(di-t-butylphosphino)ferrocene]palladium(II) In water at 20℃; for 0.0833333h; Stage #2: With triethylamine In water at 80℃; for 12h; | 2.3.2. Compounds 1-7, 10 General procedure: Aryl bromide (0.5 mmol, 1 eq.), aryl boronic acid (1.5 mmol, 3 eq.) and Pd(dtbpf)Cl 2 (0.01 mmol, 0.02 eq.) were weighed in the test tube and 3 mL of 2 wt% of l - α-lecithin and Tween 80 (2:8) solution in water were added. The mixture was stirred for 5 min at room temperature, then Et 3 N (3 mmol, 6 eq.) was added. After 12 h, the mixture was diluted with 20 mL of MeOH and filtered. |
94% | With tetrakis(triphenylphosphine) palladium(0); 18-crown-6 ether; potassium carbonate In ethanol; water; toluene at 105℃; for 3h; Inert atmosphere; | |
72% | With dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; water; palladium diacetate; cesium fluoride; 1,5-cyclooctadiene at 120℃; for 1.5h; Milling; |
72 % | With dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; palladium diacetate; cesium fluoride; 1,5-cyclooctadiene In water at 250℃; Sealed tube; Milling; | 1 [Example 1] 0.15 mmol (1.0 eqiv) of compound A shown in Scheme 1 and 0.36 mmol of compound B (relative to compound A 2.4 eqiv), 0.015 mmol of Pd(OAc) as a metal catalyst (10 mol % with respect to compound A), and 0.0225 mmol of SPhos as a phosphine compound.(15 mol% with respect to compound A), 0.9 mmol of CsF as a base (6.0 eqiv with respect to compound 1), 1.08 mmol of water as a reaction accelerator (7.2 eqiv with respect to compound A), unsaturated 0.2 μL/mg of 1,5-cyclooctadiene was added as a hydrocarbon compound. The lid of the ball mill jar was closed, the ball mill was mounted, and the jar was heated with a heat gun set at 250° C. while being shaken (30 Hz) and stirred for 90 minutes to carry out a cross-coupling reaction.After completion of the reaction, the reaction mixture was extracted with dichloromethane and dried over magnesium sulfate. Then, after removing dichloromethane with an evaporator, the target compound 1 was isolated by purifying the reaction mixture with silica gel column chromatography. Isolated yield was 72%. |
82 % | With water; palladium diacetate; cesium fluoride; 1,5-cyclooctadiene In neat (no solvent) at 80℃; Milling; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: potassium carbonate; tetrakis(triphenylphosphine) palladium(0); 18-crown-6 ether / water; ethanol; toluene / 3 h / 105 °C / Inert atmosphere 2: tetrahydrofuran / 17 h / -10 - 20 °C / Inert atmosphere 3: hydrogenchloride; tin(ll) chloride / tetrahydrofuran; water / 0.08 h / 20 °C / Inert atmosphere |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: potassium carbonate; tetrakis(triphenylphosphine) palladium(0); 18-crown-6 ether / water; ethanol; toluene / 3 h / 105 °C / Inert atmosphere 2: tetrahydrofuran / 4 h / -78 - -40 °C / Inert atmosphere |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: potassium carbonate; tetrakis(triphenylphosphine) palladium(0); 18-crown-6 ether / water; ethanol; toluene / 3 h / 105 °C / Inert atmosphere 2: tetrahydrofuran / 4 h / -78 - -40 °C / Inert atmosphere 3: hydrogenchloride; tin(II) chloride dihdyrate / tetrahydrofuran; hexane / 1 h / 20 °C / Inert atmosphere | ||
Multi-step reaction with 3 steps 1: potassium carbonate; tetrakis(triphenylphosphine) palladium(0); 18-crown-6 ether / water; ethanol; toluene / 3 h / 105 °C / Inert atmosphere 2: tetrahydrofuran / 4 h / -78 - -40 °C / Inert atmosphere 3: hydrogenchloride; tin(II) chloride dihdyrate / tetrahydrofuran; water / 5 h / 20 °C / Inert atmosphere |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
29% | With bis-triphenylphosphine-palladium(II) chloride; copper(l) iodide; diisopropylamine In 1,2-dichloro-benzene at 80℃; for 17h; Schlenk technique; Inert atmosphere; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
62% | With tris(1-adamantyl)phosphine; palladium diacetate; triethylamine In water at 80℃; for 1h; Milling; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
21% | Stage #1: 4,10-dibromoanthanthrone; (2,6-dimethoxyphenyl)boronic acid With dichloro[1,1'-bis(di-t-butylphosphino)ferrocene]palladium(II) In water at 20℃; for 0.0833333h; Stage #2: With triethylamine In water at 80℃; for 12h; | 2.3.2. Compounds 1-7, 10 General procedure: Aryl bromide (0.5 mmol, 1 eq.), aryl boronic acid (1.5 mmol, 3 eq.) and Pd(dtbpf)Cl 2 (0.01 mmol, 0.02 eq.) were weighed in the test tube and 3 mL of 2 wt% of l - α-lecithin and Tween 80 (2:8) solution in water were added. The mixture was stirred for 5 min at room temperature, then Et 3 N (3 mmol, 6 eq.) was added. After 12 h, the mixture was diluted with 20 mL of MeOH and filtered. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66% | With tripotassium phosphate tribasic; copper (I) iodide; C21H16N2O In sulfolane at 100℃; for 24h; Inert atmosphere; Sealed tube; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80 % | With Aliquat 336; sodium thiosulfate; sodium hydroxide at 60℃; Inert atmosphere; | 1 Synthesis of 4,10-dibromo-6,12-bis(2-octyldodecyloxy)anthracene (C20AAN) Under nitrogen protection,Reduced orange 3 (2g, 4.32mmol), sodium hydroxide solution (0.1M, 200mL, 20mmol), Aliquat 336 (2.12g, 2.4mL, 5.24mmol) were installed in a 500ml one-mouth bottle, sodium thiosulfate (1.94g, 11.12mmol), and 1-bromo-2-octyl dodecane (12.44g, 34.48mmol). The reaction solution was heated to 60°C for 5h until the reaction system became colorless. The water was decanted, and then 120 mL of methanol was added.The crude product was filtered off with suction and washed with methanol. Purification by silica gel column chromatography (dichloromethane/petroleum ether 1:5v/v) gave compound C20AAN as an orange solid (3.54g, 80%). |
Tags: 4378-61-4 synthesis path| 4378-61-4 SDS| 4378-61-4 COA| 4378-61-4 purity| 4378-61-4 application| 4378-61-4 NMR| 4378-61-4 COA| 4378-61-4 structure
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :